Drug Shortage Report for ROFACT

Last updated on 2020-03-18 History
Report ID 93236
Drug Identification Number 00393444
Brand name ROFACT
Common or Proper name ROFACT
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) RIFAMPIN
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size n/a
ATC code J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-10
Estimated end date
Actual end date 2020-03-16
Shortage status Resolved
Updated date 2020-03-18
Company comments new lots are in transit
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v34 2020-03-18 French Compare
v33 2020-03-18 English Compare
v32 2020-03-12 French Compare
v31 2020-03-12 English Compare
v30 2020-03-12 English Compare
v29 2020-02-28 French Compare
v28 2020-02-28 English Compare
v27 2020-02-03 French Compare
v26 2020-02-03 English Compare
v25 2020-02-03 French Compare
v24 2020-02-03 English Compare
v23 2020-01-16 French Compare
v22 2020-01-16 English Compare
v21 2020-01-15 French Compare
v20 2020-01-15 English Compare
v19 2020-01-10 English Compare
v18 2020-01-09 French Compare
v17 2020-01-09 English Compare
v16 2019-12-17 English Compare
v15 2019-12-11 French Compare

Showing 1 to 20 of 34